3 unchanged sentences
Pursuant to a lease agreement, dated August 1,
−Removed: 2021, and renewed in 2022, the Company leased the space for a total average monthly cost of $11,000.
−Removed: For 2022, the lease agreement was
−Removed: renewed at an average monthly rent rate of approximately $6,400.
+Added: 2021, and renewed in 2022 and 2023, the Company leased the space for a total average monthly cost of $11,000.
+Added: For 2022, the lease agreement
+Added: was renewed at an average monthly rent rate of approximately $9,000.
+Added: For 2023, the lease agreement was renewed at an average monthly rent
+Added: rate of approximately $7,000.
Effective July 31, 2021, the Company terminated
1 unchanged sentence
corporate headquarters.
−Removed: On June 8, 2017, the Company entered into an Amended and Restated License
−Removed: Agreement (the Actinium License) with Actinium Pharmaceuticals, Inc.
−Removed: (Actinium) for office space located at 275 Madison Avenue, 7th Floor,
−Removed: New York, New York 10016, our former corporate headquarters.
−Removed: This agreement amends and restates the license agreement entered into between
−Removed: the parties on March 10, 2016 (the Lease Agreement).
−Removed: Pursuant to the terms of the Actinium License, Actinium will continue to license
−Removed: the furniture, fixtures, equipment and tenant improvements located in its office (the FFE) for a license fee of $7,529 per month until
−Removed: December 8, 2022.
−Removed: Actinium shall have at any time during the term of this Lease Agreement the right to purchase the FFE for $496,914,
−Removed: less any previously paid license fees.
−Removed: The license of FFE qualifies as a sales-type lease.
−Removed: At inception, the Company derecognized the
−Removed: underlying assets of $493,452, recognized discounted lease payments receivable of $397,049 using the discount rate of 8.38% and recognized
−Removed: loss on sales-type lease of fixed assets of $96,403.
−Removed: The term of the Actinium License is contemporaneous with the Lease Agreement.
+Added: On June 8, 2017, the Company entered into an
+Added: Amended and Restated License Agreement (the Actinium License) with Actinium Pharmaceuticals, Inc.
+Added: (Actinium) for office space located
+Added: at 275 Madison Avenue, 7th Floor, New York, New York 10016, our former corporate headquarters.
+Added: This agreement amends and restates the
+Added: license agreement entered into between the parties on March 10, 2016 (the Lease Agreement).
+Added: Pursuant to the terms of the Actinium License,
+Added: Actinium will continue to license the furniture, fixtures, equipment and tenant improvements located in its office (the FFE) for a license
+Added: fee of $7,529 per month until December 8, 2022.
+Added: On July 7, 2022, Actinium exercised its right to purchase the FFE for $52,698.
+Added: Beginning on January 1, 2023, we also leased office space at 880 Third
+Added: Avenue, 12 th Floor, New York, NY 10022 for approximately $15,000 per month, that expires on December 31, 2023.
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.